We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WDH:NYSEWaterdrop Inc. Analysis

Data as of 2026-05-28 - not real-time

$1.53

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Waterdrop Inc. (WDH) is trading at $1.53, well below its 20‑day SMA of $1.57 and the 200‑day SMA of $1.76, signaling a bearish short‑term price bias. The 14‑day RSI sits at 44, indicating the stock is not yet oversold, while the MACD histogram remains negative, confirming bearish momentum. Despite this technical weakness, the stock’s trailing P/E of 6.9 is dramatically lower than the industry average of 16.6, and its price‑to‑book of 0.74 underscores deep value. A dividend yield of 3.9% coupled with a modest payout ratio of 24% suggests the dividend is comfortably sustainable. Volatility over the past 30 days is high at roughly 40%, and beta above 1 points to heightened systematic risk. Nonetheless, the fair‑value DCF estimate of $19.7 implies a substantial upside potential.
The company posted $3.98 billion in revenue with 5.5% year‑over‑year growth and a healthy gross margin of 51%, while operating and profit margins of 5.9% and 14.3% respectively demonstrate operational efficiency. Return on equity of 11% and a strong cash position of $1.0 billion against only $70 million of debt provide a solid balance sheet. Analysts’ consensus is a “strong buy” with a median target price of $2.45, indicating expectations of a roughly 60% price appreciation. However, exposure to China’s regulated insurance market introduces notable regulatory and geopolitical risk. The stock’s liquidity is moderate, with average daily volumes around 200k shares and a market cap of $550 million. Overall, the combination of deep valuation discounts, attractive dividend, and resilient fundamentals makes WDH a compelling value opportunity, albeit with elevated risk factors.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price below key moving averages suggests potential rebound
  • Strong dividend yield supports total return
  • Technical momentum still bearish but improving volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst target median $2.45 indicates upside
  • Fundamentals show solid margins and cash generation
  • Valuation metrics (P/E, P/B) far below peers

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair value suggests substantial long‑term upside
  • Sustainable dividend provides income cushion
  • Low valuation multiples position stock for multi‑year appreciation

Key Metrics & Analysis

Financial Health

Revenue Growth105.50%
Profit Margin14.30%
P/E Ratio7.0
ROE11.27%
ROA3.42%
Debt/Equity1.37
P/B Ratio0.7
Op. Cash Flow$243.9M
Free Cash Flow$-77580752
Industry P/E16.6

Technical Analysis

TrendBearish
RSI43.7
Support$1.43
Resistance$1.70
MA 20$1.57
MA 50$1.63
MA 200$1.76
MACDBearish
VolumeIncreasing
Fear & Greed Index92.34

Valuation

Fair Value$19.71
Target Price$2.31
Upside/Downside51.22%
GradeUndervalued
TypeValue
Dividend Yield3.92%

Risk Assessment

Beta1.11
Volatility39.94%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.